Document is current

Any future updates will be listed below

Baricitinib zum Erhalt der Betazellfunktion bei Typ-1-Diabetes

Crossref DOI link: https://doi.org/10.1007/s11428-024-01154-4

Published Online: 2024-01-25

Published Print: 2024-03

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark